Connect with us

Hi, what are you looking for?

Travel Vaccines Market: Introspective Market Research Uncovers the Reasons for Market Growth at a CAGR of 8.85% by Value to Reach $18.27 Million by 2028

Market Overview:

Travel Vaccines Market size is projected to reach USD 18.27 billion by 2028 from an estimated USD 10.09 billion in 2021, growing at a CAGR of 8.85% globally.

Travel vaccines are also known as travel immunizers vaccines. These vaccines are used as a precaution before visiting any region to prevent any serious disease. After vaccination, the body creates antibodies with the help of the vaccine to take care of several diseases. The bio-based formulation is used to make travel vaccines and it also contains weakened or dead form micro-organisms. This vaccine gives immunity to diseases. Travel vaccines include routine vaccines, recommended vaccines, and required vaccines. Routine vaccines contain most national health programs and it is given to children but a booster dose is required to provide effective immunity. Recommended vaccines are given to individual travelers who are traveling to places where high risk of diseases. Required vaccines include only three vaccines such as yellow fever, meningococcal, and polio vaccines. The purpose of travel vaccine is the first step toward healthy and smart traveling which support the growth of the travel vaccine market.

Request a free sample copy: –  

Major Key Players for Travel Vaccines:

  • Pfizer
  • Sanofi
  • GlaxoSmithKline
  • Merck
  • AstraZeneca
  • Janssen Pharmaceuticals
  • Abbott
  • Mitsubishi Tanabe Pharma
  • LG Life Sciences
  • Roche
  • Lupin
  • Takeda Pharmaceutical
  • Valeant Pharmaceuticals
  • SK Chemicals
  • Hualan Biological Engineering

Market Dynamics and Factors:

The rising coronavirus is anticipated to have growth in the market. The coronavirus (COVID-19) pandemic change the phenomenon of traveling in 2020. In 2021, several countries started to discuss the idea of introducing vaccine passports for international travel, only allowing vaccinated people to travel abroad, as a way of launching the tourism industry. According to Statista as of June 13, 2022, almost 12 billion COVID-19 vaccine doses had been administered worldwide, with the United States accounting for about 590 million of these totals. Traveling in developing countries and rural areas brings into contact with more diseases, which means might need more vaccines before traveling. For instance, In South America and central countries of Africa tourist’s wants to travel should get vaccinated for Yellow Fever. Additionally, The Canadian government also dropped the requirement that domestic and outbound international travelers have to be fully vaccinated in 2020. These factors propel the growth of the market in the forecast period.

Inquiry Before Purchase: –

Travel Vaccines Report Highlight:

  • By type, the combination vaccines segment is expected to have the maximum market share in travel vaccines during the projected period. The combination vaccines are cost-effective, decline the number of injections, clarify the immunization schedule, and reduce the risk of diseases which is anticipated for the growth of the market.
  • By application, the outbound travel segment is predicted to expand the most in the travel vaccines market during the forecast year. The rising number of outbound tourism boosts the growth of the market.
  • By region, North America is expected to dominate the travel vaccines market, during the projection period. The rising number of travelers, advanced technology, and government initiatives, support the market growth in the projected period.

Key Industry Development:

  • In March 2021, In Toronto, Canada the Sanofi invested more than US$ 750 million in a new manufacturing vaccine facility. The name of that vaccine is Sanofi’s Fluzone High-Dose Quadrivalent influenza vaccine.
  • In June 2021, the Vaxelis vaccine (Diphtheria and Tetanus Toxoids and Acellular Pertussis, Inactivated Poliovirus, Haemophilus b Conjugate, and Hepatitis B Vaccine) was developed by Sanofi and Merck & Co., Inc. It is considered the first hexavalent combination vaccine which is used to prevent DTP, polio, and hepatitis B.

Travel Vaccines Segmentation:

By Type

  • Mono Vaccines
  • Combination Vaccines
  • Others

By Application

  • Domestic Travel
  • Outbound Travel
  • Other

Customized Report: –

For this report, Introspective Market Research has segmented the Travel Vaccines Market based on region:

Regional Outlook (Revenue in USD Million; Volume in Units, 2022-2028)

  • North America
    • The U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Turkey
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Indonesia
    • Vietnam
    • Thailand
    • Rest of Asia-Pacific
  • Middle East & Africa
    • Saudi Arabia
    • South Africa
    • Iran
    • Rest of MEA
  • Latin America
    • Brazil
    • Argentina
    • Rest of LATAM

Purchase the Report: – 

Scope of the Report:

The objective of the research is to provide the market knowledge and strategic insights to assist decision-makers in making informed investment decisions and identifying potential gaps and growth opportunities. Historical revenue and sales volume are reported, and additional data is triangulated using top-down and bottom-up methodologies to predict forecast numbers for important regions covered in the research, as well as classified and well-known Types and end-use industries. Travel Vaccine Market study explores the competitive landscape of the global market.  In addition to rival market share research, in-depth profiling, product/service, and business overviews, the study focuses on BCG matrix, heat map analysis, and SWOT analysis to better correlate market competitiveness. Five forces analysis, Ansoff matrix, PESTEL analysis, and value chain analysis are used to better understand market conditions.

Purchase This Report: –


Read IMR News:,at%20a%20CAGR%20of%2012.7%25.

About us:

Introspective Market Research ( is a visionary research consulting firm dedicated to assisting our clients to grow and have a successful impact on the market. Our team at IMR is ready to assist our clients to flourish their business by offering strategies to gain success and monopoly in their respective fields. We are a global market research company, that specializes in using big data and advanced analytics to show the bigger picture of the market trends. We help our clients to think differently and build better tomorrow for all of us. We are a technology-driven research company, we analyze extremely large sets of data to discover deeper insights and provide conclusive consulting. We not only provide intelligence solutions, but we help our clients in how they can achieve their goals.

Contact us:

Introspective Market Research

3001 S King Drive,

Chicago, Illinois

60616 USA

Ph no: +1-773-382-1047

Linkedin| Twitter| Facebook

Written By

You may also like:


Tesla reported another round of record quarterly profits while confirming its long-term growth outlook.


There has been a significant increase in the number of finance firms using AI to detect fraudulent business activities.

Social Media

Meta announced it would soon reinstate former president Donald Trump's accounts on Facebook and Instagram.


Hong Kong stocks have rallied more than 10 percent since the turn of the year - Copyright AFP DALE DE LA REYMost Asian markets...